http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#head http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#assertion http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#provenance http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#publicationInfo http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#assertion http://bio2rdf.org/drugbank:DB05489 http://bio2rdf.org/bio2rdf_vocabulary:identifier DB05489 http://bio2rdf.org/drugbank:DB05489 http://bio2rdf.org/bio2rdf_vocabulary:namespace drugbank http://bio2rdf.org/drugbank:DB05489 http://bio2rdf.org/bio2rdf_vocabulary:uri http://bio2rdf.org/drugbank:DB05489 http://bio2rdf.org/drugbank:DB05489 http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org http://identifiers.org/drugbank/DB05489 http://bio2rdf.org/drugbank:DB05489 http://bio2rdf.org/drugbank_vocabulary:drugbank-id DB05489 http://bio2rdf.org/drugbank:DB05489 http://bio2rdf.org/drugbank_vocabulary:x-cas http://bio2rdf.org/cas: http://bio2rdf.org/drugbank:DB05489 http://purl.org/dc/terms/description An IgG1 murine monoclonal anti-idiotype antibody (Ab2), ACA-125, was developed to bind to anti-CA 125 antibodies. ACA-125 mimics the tumor-associated antigen CA-125, which can be detected in about 80% of ovarian carcinomas. This new concept of oncological immunotherapy consists of an attempt to trigger the immune system of the host to respond against tumor cells. Antiidiotypic antibodies bearing the internal image of an antigen expressed on the surface of the tumor are suited to this approach. To create ACA-125, a hybridoma cell was adapted to serum-free medium and antibody was produced in a hollow fiber cell culture system. Positive clinical results are now being reported. http://bio2rdf.org/drugbank:DB05489 http://purl.org/dc/terms/identifier drugbank:DB05489 http://bio2rdf.org/drugbank:DB05489 http://purl.org/dc/terms/title ACA 125 http://bio2rdf.org/drugbank:DB05489 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug http://bio2rdf.org/drugbank:DB05489 http://www.w3.org/2000/01/rdf-schema#label ACA 125 [drugbank:DB05489] http://bio2rdf.org/drugbank:DB05489 http://www.w3.org/2000/01/rdf-schema#seeAlso http://www.drugbank.ca/drugs/DB05489 http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#provenance http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://www.w3.org/ns/dcat#distribution http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://purl.org/dc/terms/created 2015-01-09T17:00:50-05:00 http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz http://www.w3.org/ns/prov#wasDerivedFrom http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00 http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00 http://purl.org/pav/retrievedOn 2014-11-12T07:57:03-05:00 http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00 http://www.w3.org/ns/prov#wasDerivedFrom http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip http://www.w3.org/ns/prov#wasAttributedTo http://drugbank.ca http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#publicationInfo http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#signature.MC0CFQCAsnC6L3jo http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#signature.MC0CFQCAsnC6L3jo http://purl.org/nanopub/x/hasSignature MC0CFQCAsnC6L3joPSSDhVfqss1C+kYgQwIUc2scC95Q6Pf4iA7Tk3+pLEjDryM= http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#signature.MC0CFQCAsnC6L3jo http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg http://purl.org/dc/terms/created 2018-03-30T11:11:15.041+02:00 http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg#signature.MC0CFQCAsnC6L3jo http://bio2rdf.org/drugbank:DB05489_nanopub.RAp1HjI6jBBp2_6xjkw-rGevyzB4DLQL9C1cC9FTBOWOg http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://purl.org/dc/terms/identifier 7720f136-841b-4851-a6e4-ad20a409a475 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234